These prognostic features are consistent with those of many other breast cancer prognostic signatures [60], [76]–[80] but different than those of subtype-specific prognostic predictors (GENIUS) that can be applied to breast cancer samples with ER-negative or HER2-negative status [7]. Here, ERBB2 is linked to breast cancer.